Every fall, millions of Americans sit down with a stack of glossy brochures and try to pick between Medicare Advantage and a Medigap supplement.
The ads make it sound simple: one is cheap, the other is thorough.
What the ads skip is who profits from each pitch, and why the "cheaper" option can quietly cost you more.
Advantage plans often advertise $0 premiums, which sounds unbeatable next to a supplement that might run $150 to $250 a month.
But that $0 plan still comes with copays, coinsurance, and an annual out-of-pocket maximum that can hit $8,000 or more for in-network care.
A supplement's higher premium buys something specific: it caps what you owe, often to nearly nothing, and lets you see any provider who takes Medicare.
Your doctor can be "in network" this year and gone the next, and referrals or prior authorizations can slow down care.
Supplements don't manage your care, which is exactly why they cost more upfront.
If you choose Advantage when you first enroll and later want to switch to a supplement, you may face medical underwriting in most states.
That means a health condition discovered in the meantime can get you denied or charged more.
In a handful of states, you can switch more freely, but most Americans don't live in one of them.
This one-way door is why advisors often say the first choice matters more than any later one.
Advantage plans are heavily advertised because insurers receive government payments per enrollee, and they compete hard for that business.
Supplements pay agents commissions too, so neither side is neutral.
Your job is to ignore the sales pitch and run your own numbers: premiums, expected copays, drug costs, and which doctors you actually want.
The honest answer is that neither option wins for everyone.
If you're healthy, rarely see specialists, and want low monthly costs, an Advantage plan can work.
If you have chronic conditions, travel, or simply hate surprise bills, a supplement plus a drug plan often buys peace of mind worth the premium.
What most people need isn't a viral slogan.
It's a calculator, a list of their medications, and a hard look at the fine print they were never handed.
Our take: this decision rewards the patient who reads the boring documents and punishes the one who trusts the flashiest ad.
Final Thoughts
Treat the enrollment window like a contract, not a coupon, and assume every "free" pitch has a catch buried on page twelve.